Details for New Drug Application (NDA): 209158
✉ Email this page to a colleague
NDA 209158 describes BRIMONIDINE TARTRATE, which is a drug marketed by Padagis Israel, Alembic, Apotex, Bausch And Lomb, Dr Reddys Labs Sa, Indoco, Lupin Ltd, Micro Labs, Rising, Sandoz, Somerset Theraps Llc, Teva Parenteral, Upsher Smith Labs, Florida, Glenmark Pharms Ltd, Sentiss, and Somerset, and is included in twenty-six NDAs. It is available from twelve suppliers. Additional details are available on the BRIMONIDINE TARTRATE profile page.
The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
Summary for 209158
| Tradename: | BRIMONIDINE TARTRATE |
| Applicant: | Padagis Israel |
| Ingredient: | brimonidine tartrate |
| Patents: | 0 |
Pharmacology for NDA: 209158
| Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for 209158
Suppliers and Packaging for NDA: 209158
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE | brimonidine tartrate | GEL;TOPICAL | 209158 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-078 | 45802-078-30 | 1 BOTTLE, PUMP in 1 CARTON (45802-078-30) / 30 g in 1 BOTTLE, PUMP |
| BRIMONIDINE TARTRATE | brimonidine tartrate | GEL;TOPICAL | 209158 | ANDA | Bryant Ranch Prepack | 63629-9616 | 63629-9616-1 | 1 BOTTLE, PUMP in 1 CARTON (63629-9616-1) / 30 g in 1 BOTTLE, PUMP |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | EQ 0.33% BASE | ||||
| Approval Date: | Sep 23, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
